ILIKANNU'S TRIA
Not Applicable
- Conditions
- Pregnancy and Childbirth
- Registration Number
- PACTR202206623958155
- Lead Sponsor
- DR ILIKANNU SAMUEL OKWUCHUKW
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Female
- Target Recruitment
- 146
Inclusion Criteria
1.Willingness and consent to participate in the study
2.All patients above 20weeks of gestation with severe preeclampsia
3.Patients without contraindication to the use of MgSO4 (e.g drug hypersensitivity, myasthenia gravis, anuria/oliguria).
Exclusion Criteria
1.Eclampsia
2.Seizure disorder patients
3.Severe preeclampsia with complications like Acute renal failure, Heart failure, HELLP syndrome, pulmonary oedema
4.Prior intake of any anticonvulsant before presentation
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method OCCURENCE OF SEIZURES IN BOTH ARM
- Secondary Outcome Measures
Name Time Method TOTAL DOSE OF MGSO4 ADMINISTERED, DURATION OF URETHRAL CATHETERIZATION IN DAYS, DURATION OF HOSPITAL STAY IN DAYS, OCCURENCE OF MATERNAL MORTALITY, ADVERSE EFFECTS AND EVIDENCE OF TOXICITY CLINICALLY, MODE OF DELIVERY, ADMISSION INTO ICU, NEED TO RECOMMENCE MGSO4